Is It Time To Reconsider Agilent Technologies (A) After Recent Share Price Weakness

FierceBiotechBiogen inks $1B RayThera buyout to bag preclinical immunology assets

Endpoints NewsModerna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs

Endpoints NewsEli Lilly's TuneLab hits 100 members, adding Chai's AI models

CellChloroplast sunscreening by protein condensates confers high-light tolerance

FierceBiotechF2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 test

Endpoints NewsAntifungal from F2G, Shionogi succeeds in Phase 3 study

Roche MediaPartnering for Sustainable Healthcare: Roche Stands with Taiwan to Build an Innovation-Friendly Biomedical Ecosystem - Taiwan Business TOPICS

BioPharma DiveKardigan extends biotech’s streak of big IPOs with $400M haul

Endpoints NewsKardigan raises $400M in IPO to back three clinical-stage cardio drugs

Endpoints NewsBiogen makes up to $1B deal for secretive anti-inflammatory biotech

eLifeConstraints on the G1/S transition pathway may favor selection of multicellularity as a passenger phenotype

FierceBiotech‘We think about it every day’: How Daiichi Sankyo’s R&D chief plans to stay ahead in the ADC game